Heron Therapeutics (HRTX) Interest Coverage Ratio (2012 - 2017)
Heron Therapeutics (HRTX) reported Interest Coverage Ratio of 492.99 for Q1 2017, down 47.99% on a YoY basis from 947.91 in Q1 2016, and down 1237.73% quarter-over-quarter from 36.85 in Q4 2016.
Heron Therapeutics (HRTX) Interest Coverage Ratio (2012 - 2017) Analysis & Trends
Heron Therapeutics has reported Interest Coverage Ratio for 6 years, with the latest figure at 492.99 in Q1 2017.
- For the quarter ending Q1 2017, Interest Coverage Ratio fell 47.99% year-over-year to 492.99; the trailing twelve-month figure through Dec 2017 stood at 1945.58 (down 2760.63% YoY), and the FY2025 full-year result was 0.26, up 86.17% from the prior year.
- Interest Coverage Ratio for Q1 2017 stood at 492.99, down from 36.85 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 51.71 in Q4 2014, with the low at 492.99 in Q1 2017.
- Historically, Interest Coverage Ratio has averaged 121.54 across 5 years, with a median of 85.41 in 2014.
- Annual changes were most pronounced in 2013 — Interest Coverage Ratio sank 660.75% — and 2014, when it jumped 179.26%.
- Heron Therapeutics' Interest Coverage Ratio stood at 65.24 in 2013, then surged by 179.26% to 51.71 in 2014, then slumped by 343.18% to 125.75 in 2015, then jumped by 70.69% to 36.85 in 2016, then plunged by 1237.73% to 492.99 in 2017.
- The last three Interest Coverage Ratio figures came in at 492.99 (Q1 2017), 36.85 (Q4 2016), and 53.88 (Q3 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -492.99 |
| Dec 31, 2016 | -36.85 |
| Sep 30, 2016 | -53.88 |
| Jun 30, 2016 | -167.57 |
| Mar 31, 2016 | -333.12 |
| Dec 31, 2015 | -125.75 |
| Sep 30, 2015 | -92.94 |
| Jun 30, 2015 | -97.11 |
| Mar 31, 2015 | -87.76 |
| Dec 31, 2014 | 51.71 |
| Sep 30, 2014 | -84.61 |
| Jun 30, 2014 | -85.41 |
| Mar 31, 2014 | -80.19 |
| Dec 31, 2013 | -65.24 |
| Sep 30, 2013 | -60.59 |
| Jun 30, 2013 | -74.19 |
| Mar 31, 2013 | -179.61 |
| Mar 31, 2012 | -23.61 |